Distinct fibronectin splicing variants: potential targets for therapeutic immunomodulation in organ allograft recipients

Transplant Proc. 1997 Feb-Mar;29(1-2):1060-1. doi: 10.1016/s0041-1345(96)00382-x.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alternative Splicing*
  • Animals
  • Fibronectins / biosynthesis*
  • Fibronectins / chemistry
  • Fibronectins / immunology
  • Genetic Variation
  • Heart Transplantation / immunology*
  • Heart Transplantation / pathology
  • Immunosuppression Therapy / methods
  • Integrin alpha4beta1
  • Integrins / antagonists & inhibitors
  • Integrins / physiology
  • Peptide Fragments / pharmacology*
  • Rats
  • Rats, Inbred Lew
  • Rats, Inbred Strains
  • Receptors, Lymphocyte Homing / antagonists & inhibitors
  • Receptors, Lymphocyte Homing / physiology
  • Receptors, Very Late Antigen / immunology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / pathology
  • Time Factors
  • Transplantation, Homologous

Substances

  • Fibronectins
  • Integrin alpha4beta1
  • Integrins
  • Peptide Fragments
  • Receptors, Lymphocyte Homing
  • Receptors, Very Late Antigen